SDS

_____________________________________________________________________________________________
1540097 - Simiron Activator Revision Date 13-Sep-2019
Inhalation
Specific test data for the substance or mixture is not available. Corrosive by inhalation.
(based on components). Inhalation of corrosive fumes/gases may cause coughing, choking,
headache, dizziness, and weakness for several hours. Pulmonary edema may occur with
tightness in the chest, shortness of breath, bluish skin, decreased blood pressure, and
increased heart rate. Inhaled corrosive substances can lead to a toxic edema of the lungs.
Pulmonary edema can be fatal. Harmful by inhalation.
Eye contact
Specific test data for the substance or mixture is not available. Causes burns. (based on
components). Corrosive to the eyes and may cause severe damage including blindness.
Causes serious eye damage. May cause irreversible damage to eyes.
Skin contact
Specific test data for the substance or mixture is not available. Corrosive. (based on
components). Causes burns. May cause sensitization by skin contact. Repeated or
prolonged skin contact may cause allergic reactions with susceptible persons. May be
absorbed through the skin in harmful amounts. Harmful in contact with skin.
Ingestion
Specific test data for the substance or mixture is not available. Causes burns. (based on
components). Ingestion causes burns of the upper digestive and respiratory tracts. May
cause severe burning pain in the mouth and stomach with vomiting and diarrhea of dark
blood. Blood pressure may decrease. Brownish or yellowish stains may be seen around the
mouth. Swelling of the throat may cause shortness of breath and choking. May cause lung
damage if swallowed. May be fatal if swallowed and enters airways.
Symptoms related to the physical, chemical and toxicological characteristics
Symptoms
Redness. Burning. May cause blindness. Coughing and/ or wheezing. Itching. Rashes.
Hives.
Numerical measures of toxicity
Acute Toxicity
The following values are calculated based on chapter 3.1 of the GHS document .
ATEmix (oral)
422.00 mg/kg
ATEmix (dermal)
1,695.90 mg/kg
ATEmix (inhalation-dust/mist)
1.50 mg/L
Unknown acute toxicity
85 % of the mixture consists of ingredient(s) of unknown toxicity
0 % of the mixture consists of ingredient(s) of unknown acute oral toxicity
0 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity
85 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas)
85 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor)
85 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist)
Component Information
Chemical name Oral LD50 Dermal LD50 Inhalation LC50
Supplier Trade Secret = 242 mg/kg ( Rat ) = 2980 mg/kg ( Rabbit ) -
Supplier Trade Secret = 1030 mg/kg ( Rat ) > 2000 mg/kg ( Rat ) -
Supplier Trade Secret = 1230 mg/kg ( Rat ) = 2 g/kg ( Rabbit ) = 8.8 mg/L ( Rat ) 4 h
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Skin corrosion/irritation
Classification based on data available for ingredients. Causes burns.
Serious eye damage/eye irritation
Classification based on data available for ingredients. Risk of serious damage to eyes.
Causes burns.
Respiratory or skin sensitization
May cause sensitization by skin contact.
_____________________________________________________________________________________________
Page 7 / 12